Showing 4171-4180 of 5646 results for "".
- Report: Diagnosed Cases of AMD in the Seven Major Markets Expected to Grow Over Next 10 Yearshttps://modernod.com/news/report-diagnosed-cases-of-amd-in-the-seven-major-markets-expected-to-grow-over-next-10-years/2480979/Diagnosed prevalent cases of age-related macular degeneration (AMD) in the seven major markets combined is expected to increase from 33.66 million cases in 2021 to 40.32 million in 2031, at an annual growth rate (AGR) of 1.98%, according to GlobalData. Of the seven major mark
- Verana Health Presents Geographic Atrophy and Diabetic Macular Edema Research at ASRS 2022https://modernod.com/news/verana-health-presents-geographic-atrophy-and-diabetic-macular-edema-research-at-asrs-2022/2480976/Verana Health delivered two podium presentations at the American Society of Retina Specialists annual meeting in New York City on July 15. The research findings were generated through analysis of Ophthalmology Qdata, real-world data resulting from the curation
- Apellis Announces FDA Acceptance and Priority Review of the NDA for Pegcetacoplan for the Treatment of Geographic Atrophyhttps://modernod.com/news/apellis-announces-fda-acceptance-and-priority-review-of-the-nda-for-pegcetacoplan-for-the-treatment-of-geographic-atrophy/2480973/Apellis Pharmaceuticals announced that the FDA has accepted and granted Priority Review designation for the intravitreal pegcetacoplan new drug application (NDA). Pegcetacoplan is an investigational, targeted C3 therapy for the treatment of geographic atrophy (GA) secondary to age-relat
- New App Allows Surgeons to Search for FDA Approved IOLshttps://modernod.com/news/new-app-allows-surgeons-to-search-for-fda-approved-iols/2480969/Matt Hirabayashi, MD, of eyeflymd.com, and Gurpal Virdi, MD, of Eyelabs.ai, have developed an app called “eyeSpace,” which is designed to allow surgeons and trainees to
- American Academy of Optometry Launches Nationwide Search for New CEOhttps://modernod.com/news/american-academy-of-optometry-launches-nationwide-search-for-new-ceo/2480968/The American Academy of Optometry (AAO) has formed a search committee to identify candidates for the position of Chief Executive Officer. Current Chief Financial Officer (CFO)/Deputy CEO Richard Jones will serve as Interim Chief Executive Officer throughout the search. Mr. Jones has more than 20
- Genentech: New 2-Year Data Confirm Vabysmo Improves Vision With Fewer Treatments for Wet AMDhttps://modernod.com/news/genentech-new-two-year-data-confirm-vabysmo-improves-vision-with-fewer-treatments-for-people-with-wet-amd/2480965/Genentech announced new 2-year data from the TENAYA and LUCERNE studies that reinforce the long-term efficacy, safety and durability of Vabysmo (faricimab-svoa) in wet age-related macular degeneration (AMD). The 2-year data were presented at the 2022 American Society of Retina Specialis
- Waldo Launches Hydra Boost Plus Lenses in the United Stateshttps://modernod.com/news/waldo-launches-hydra-boost-plus-lenses-in-the-united-states/2480962/Waldo announced the launch of Hydra Boost Plus contact lenses, now available at
- Zeiss Ventures Invests in Morrow Eyewearhttps://modernod.com/news/zeiss-ventures-invests-in-morrow-eyewear/2480961/Zeiss Ventures has invested in Morrow, a high-tech start-up from Belgium developing autofocal glasses that allow people to switch between near vision and distance vision at the touch of a button. The innovative liquid crystal technology is embedded between two ultra-precise, thin-c
- Bausch + Lomb Announces Efficiency-Enhancing Upgrades for Stellaris Elite Vision Enhancement Systemhttps://modernod.com/news/bausch-lomb-announces-efficiency-enhancing-upgrades-for-stellaris-elite-vision-enhancement-system/2480960/Bausch + Lomb announced the first in a series of upgrades for the Stellaris Elite vision enhancement system designed to enhance efficiency. The upgrades include an increase to the maximum vacuum setting from 600 to 660 mmHg and an enhancement to the removable valve caps in the troc
- Study: AMD Strongly Associated With Heart Disease and Strokehttps://modernod.com/news/study-blinding-eye-disease-is-strongly-associated-with-heart-disease-and-stroke/2480958/Patients with a specific form of age-related macular degeneration (AMD) are at significant risk for cardiovascular disease and stroke, according to new research from New York Eye and Ear Infirmary of Mount Sinai. This study, published in the July issue of Retina, is the first t